Click’s Digital Therapeutic Shown To Enhance Clinical Benefit Of Migraine Drugs In Pivotal Trial

 
• By Natasha Barrow
Migraine affects more than 37 million adults and is the second leading cause of disability in the US. • Source: Shutterstock

More from Clinical Trials

More from R&D